Cash Flow - MoonLake Immunotherapeutics (MLTX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | |
|---|---|---|---|---|---|---|
| Operating cash flow | -196.01 | -116.59 | -42.78 | -55.89 | -35.18 | -0.32 |
| Cash flow from investing | 202.99 | -205.60 | -25.18 | -32.34 | -0.05 | -115.00 |
| Cash flow from financing | 146.00 | 51.31 | 479.70 | 119.69 | 43.26 | 116.65 |
| Change in cash | 152.98 | -270.87 | 411.74 | 31.46 | 8.04 | 1.34 |
Show Quarterly Cash Flow
Cash Flow - MoonLake Immunotherapeutics (MLTX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -66.29 | -58.79 | -44.54 | -54.53 | -38.14 | -48.47 | -25.28 | -27.89 | -14.95 | -12.34 | -9.25 | -12.16 | -9.02 | -11.60 | -9.35 | -34.15 | -14.19 | -7.45 | -2.02 | 0.01 | -0.11 |
| Cash flow from investing | 0.10 | -29.91 | 88.40 | 88.25 | 56.25 | -147.33 | 58.28 | -87.74 | -28.80 | -174.38 | 12.68 | 19.65 | 9.90 | -42.23 | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 | ||
| Cash flow from financing | 30.64 | 72.40 | 0.48 | 0.00 | 73.12 | 0.15 | 0.18 | 0.00 | 50.98 | 28.42 | 0.00 | 451.29 | 451.29 | 0.00 | 119.57 | 18.54 | 15.00 | 15.00 | 0.50 | 15.00 | -0.06 |
| Change in cash | -35.54 | -16.31 | 44.34 | 33.72 | 91.23 | -195.65 | 33.19 | -115.63 | 7.23 | 16.07 | -183.63 | 451.80 | 461.91 | -1.69 | 67.99 | -15.63 | 0.80 | 7.53 | -1.53 | 14.99 | -0.17 |